Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1989 USD | -4.14% | -14.56% | -86.65% |
04-16 | Barnes & Noble Education to Receive $95 Million Investment, Adopts Short-Term Poison Pill; Shares Plunge | MT |
04-16 | Barnes & Noble Education Adopts Short-Term Poison Pill | MT |
Sales 2024 * | 1.58B 127B | Sales 2025 * | 1.62B 130B | Capitalization | 10.57M 846M |
---|---|---|---|---|---|
Net income 2024 * | -56M -4.48B | Net income 2025 * | -19M -1.52B | EV / Sales 2024 * | 0.01 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.01 x |
P/E ratio 2024 * |
-0.19
x | P/E ratio 2025 * |
-0.54
x | Employees | 3,450 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.73% |
Latest transcript on Barnes & Noble Education, Inc.
1 day | -4.14% | ||
1 week | -14.56% | ||
Current month | -72.54% | ||
1 month | -71.23% | ||
3 months | -78.19% | ||
6 months | -79.51% | ||
Current year | -86.65% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Huseby
CEO | Chief Executive Officer | 69 | 31/12/13 |
Kevin Watson
DFI | Director of Finance/CFO | 57 | 06/09/23 |
Stephen Culver
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Huseby
CEO | Chief Executive Officer | 69 | 31/12/13 |
David Golden
BRD | Director/Board Member | 66 | 01/08/15 |
John Ryan
CHM | Chairman | 79 | 21/07/15 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.1989 | -4.14% | 2,707,801 |
25/04/24 | 0.2075 | +0.24% | 1,856,749 |
24/04/24 | 0.207 | +0.29% | 1,045,448 |
23/04/24 | 0.2064 | +2.64% | 1,460,859 |
22/04/24 | 0.2011 | -13.62% | 2,514,861 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.65% | 10.57M | |
+46.67% | 210M | |
+55.63% | 69.24M |
- Stock Market
- Equities
- BNED Stock